Trial · NCT07899671
Learning in Children With Developmental Language Disorder
NCT07899671, Not applicable, Not yet recruiting, MGH Institute of Health Professions
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Learning in Children With Developmental Language Disorder. Trials, record NCT07899671. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07899671
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Learning in Children With Developmental Language Disorder
- NCT number
- NCT07899671
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 160 participants, estimated
- Lead sponsor
- MGH Institute of Health Professions
- Conditions
- Developmental Language Disorder
- Interventions
- priming
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Inter-trial coherence (ITC) to 1.8 Hz | At Visits 2 and 3 (up to approximately 4 weeks after Visit 1) | Inter-trial Coherence (ITC) is a measure of the strength of oscillatory phase-locking across trials. ITC values range from 1, reflecting completely phase-locked activity, to 0, indicating activity that is completely phase random with respect to the event of interest. |
| Primary | Word segmentation Score (triplet learning paradigm) | At Visits 2 and 3 (up to approximately 4 weeks after Visit 1) | Reaction Time Ratio: The difference in mean reaction time between the first and final syllable, divided by mean reaction time for the first syllable. |
| Primary | Word Learning Index (WLI) score (triplet learning paradigm) | At Visits 2 and 3 (up to approximately 4 weeks after Visit 1) | The ratio of Inter-Trial Coherence (ITC) of the delta range to Inter-trial Coherence (ITC) of the theta range. |
| Primary | Word Knowledge Accuracy (sentence learning paradigm) | At Visits 2 and 3 (up to approximately 4 weeks after Visit 1) | Accuracy: % correct, evaluated across 18 trials. |
| Primary | Sentence knowledge Accuracy (sentence learning paradigm) | At Visits 2 and 3 (up to approximately 4 weeks after Visit 1) | Accuracy: % correct, evaluated across 18 trials. |
| Primary | D Prime (Grammatical Discrimination) | At Visits 2 and 3 (up to approximately 4 weeks after Visit 1) | d prime (d'), evaluated across 18 trials. d'=0 indicates no distinction between the signal and noise. Hit rate matches false alarm rate. d'\>0: the higher the value, the stronger the distinction between signal and noise. d'\<0: the more negative, indicate that false alarm rate is greater than hit rate. |
| Secondary | Inter-trial coherence (ITC) to 5.4 Hz | At Visits 2 and 3 (up to approximately 4 weeks after Visit 1) | In electroencephalogram (EEG) analysis inter-trial coherence measures how consistently the phase of a specific brain wave frequency aligns across trials. (possible range is 0-1; 0 is no phase alignment; 1 is perfect phase alignment). The closer the ITC value to 1, the stronger the alignment. |
| Other | Language Standard Score | At Visit 1 (after enrollment) | Clinical Evaluation of Language Fundamentals - fifth edition (CELF-5). Standard score average is 100, Standard deviation is 15. Average range is 85-115. Higher scores reflect better performance on the test. |
| Other | Nonverbal IQ standard score | At Visit 1 (after enrollment) | Nonverbal IQ Index score (standard score) on the Kaufman brief intelligence test, second edition (K-BIT 2) to determine eligibility. Average score = 100, standard deviation (SD) = 15. Average range is 85-115. Higher scores reflect better performance on the test. |
| Other | Standard Score on rapid naming (Rapid Automatized Naming or RAN) test. | At Visit 1 (after enrollment) | Standard Score on rapid naming (Rapid Automatized Naming or RAN). Standard scores will be obtained (mean = 100, SD = 15). Average range is 85-115. Higher scores reflect better performance on the test. |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as |
|---|---|
| Serial Naming Task | Other outcome |
Source ConductCognition
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07899671
GET https://conductscience.org/api/trials/v1/NCT07899671/registered